Home > Healthcare > Medical Devices > Therapeutic Devices > Pain Management Devices Market

Pain Management Devices Market Size

  • Report ID: GMI6125
  • Published Date: Jun 2023
  • Report Format: PDF

Pain Management Devices Market Size

Pain Management Devices Market size valued at USD 4.4 billion in 2023 and is poised to grow at over 8.9% CAGR from 2024 to 2032. Favorable reimbursement policies, technological advancements, growing aging population and increasing prevalence of chronic pain are among the key attributes driving the demand for pain management devices.

 

Pain management devices are medical devices that are specifically designed to help alleviate or control pain. These devices are intended to be used as part of a comprehensive pain management plan and can provide relief for various types of pain, including chronic pain, acute pain, and postoperative pain. Pain management devices work through various mechanisms, such as electrical stimulation, thermal therapy, or drug delivery.

 

Pain management devices, especially those involving implantation or invasive procedures, undergo rigorous regulatory scrutiny to ensure safety and efficacy. The pain management devices may not be equally accessible in all regions due to variations in healthcare infrastructure, resource constraints, and healthcare disparities. Lack of availability and limited distribution channels in certain regions can hinder market growth and limit patient access to these devices. Further, pain management devices can be expensive, particularly advanced neurostimulation implants and drug delivery systems. The high cost of these devices can limit their accessibility, especially in regions with limited healthcare budgets or inadequate insurance coverage.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of pain management devices was valued at over USD 4.4 billion in 2023 and will reach around USD 9.5 billion by 2032, backed by the favorable reimbursement policies, technological advancements, growing aging population, and increasing prevalence of chronic pain.

The market share from neuropathic pain segment is projected to surpass around USD 2.8 billion by 2032, owing to the growing body of clinical evidence supporting the effectiveness of pain management devices in neuropathic pain management.

North America pain management devices market is anticipated to cross around USD 4 billion by 2032, attributed to a well-developed and advanced healthcare infrastructure with state-of-the-art hospitals, clinics, and research institutions in the region.

Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Stryker Corporation, Abbott Laboratories, Stim Wave Technologies, and Nevro Corporation among others.

Pain Management Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 522
  • Countries covered: 30
  • Pages: 220
 Download Free Sample